Optiver Holding’s Boston Scientific BSX Stock Holding History

Optiver Holding’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$447K	Sell	10,484 -3,091	-23%	-$168K	﹤0.01%	771
2026 Q1	$852K	Buy	+13,575	New	+$1.09M	﹤0.01%	574
2025 Q1	–	Sell	-2,099	Closed	-$187K	–	1363
2024 Q4	$187K	Buy	+2,099	New	+$185K	﹤0.01%	483
2024 Q3	–	Sell	-1,936	Closed	-$149K	–	957
2024 Q2	$149K	Buy	+1,936	New	+$142K	﹤0.01%	500
2022 Q1	–	Sell	-258	Closed	-$11K	–	544
2021 Q4	$11K	Hold	258	–	–	﹤0.01%	685
2021 Q3	$11K	Buy	+258	New	+$11.4K	﹤0.01%	553

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Optiver Holding's BSX Position: Q2 2026 in Review

Optiver Holding reduced its Boston Scientific (BSX) stake by 23% in Q2 2026, selling an estimated $168K and leaving 10,484 shares worth $447K. The position accounts for ﹤0.01% of the portfolio, ranked #771.

Optiver Holding first reported a position in BSX in Q3 2021 and has held it in 6 quarters since. The position peaked at $852K in Q1 2026. 1,480 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Optiver Holding held 10,484 shares of Boston Scientific worth $447K as of Q2 2026.
Optiver Holding sold 3,091 Boston Scientific shares in Q2 2026, an estimated $168K.
Boston Scientific made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #771 holding.
Optiver Holding first reported a position in Boston Scientific in Q3 2021 and has held it in 6 quarters since.
Optiver Holding's Boston Scientific position peaked at $852K in Q1 2026.
1,480 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.